Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Bryan L. Roth

31 indexed publications match this author name.

ORCID: 0000-0002-0561-6520
OpenAlex: https://openalex.org/A5007856961

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Receptor Pharmacology 17 Depression 14 Mechanism of Action 11 Safety 9 Anxiety 9 Clinical Trial 8 Pharmacology 8 Review Article 7 Headache / Migraine 6 Animal Study 5 Treatment-Resistant Depression 4 Chronic Pain 4

Journals

Expert review of neurotherapeutics 4 Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics 3 Research Square 2 UNC Libraries 2 Neuron 2 ClinicalTrials.gov 1 Nature neuroscience 1 medRxiv: the preprint server for health sciences 1

Publication history

A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10 A suite of engineered mice for interrogating psychedelic drug actions.Nature neuroscience · 2026-08-06 Comparing synthetic and biological therapy for the treatment of cluster headache: what is needed and when?Expert review of neurotherapeutics · 2026-07-23 Psilocybin-Assisted Early Palliative Care for Demoralization and Chronic Pain: An Open-Label Pilot Study.medRxiv: the preprint server for health sciences · 2026-07-14 Anthracaurisin A─Discovery of a Cytotoxic -Sesquiterpene Dimer from Patagonian.Journal of natural products · 2026-06-26 Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomised [F]FDG-PET study.Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026-06-01 Safety and Efficacy of Psilocybin in the Management of Treatment-Resistant Depression: A Systematic ReviewResearch Square · 2026-05-11 Single-dose psilocybin promotes cell-type-specific changes of neurons in the orbitofrontal cortex.Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics · 2026-01-01 CNSC-36. PSILOCYBIN INDUCES SUSTAINED GLIOMA GROWTH THROUGH SEROTONERGIC AND TRKB PATHWAYSNeuro-Oncology · 2025-11-01 Psychedelic compounds directly excite 5-HT2A layer V medial prefrontal cortex neurons through 5-HT2A Gq activationUNC Libraries · 2025-10-16 The polypharmacology of psychedelics reveals multiple targets for potential therapeutics.Neuron · 2025-10-01 A critical evaluation of psilocybin-assisted therapy protocol components from clinical trial patients, facilitators, and caregivers.Psychotherapy (Chicago, Ill.) · 2025-09-01 Esse quam Videre: Critical Reflections on the Use of Psilocybin as an Adjuvant in Psychedelic-Assisted PsychotherapyPolymatheia. · 2025-02-15 Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin ReceptorUNC Libraries · 2024-06-07 Exposure therapy under psilocybin for general anxiety disorder and claustrophobiaResearch Square · 2023-05-12 Magic Mushroom Use: A Qualitative Interview Study of Post-Trip Impacts and Strategies for Optimizing Experiences.Journal of psychoactive drugs · 2023-01-01 Adapting psychedelic medicine for headache and chronic pain disorders.Expert review of neurotherapeutics · 2023-01-01 Psychedelic compounds directly excite 5-HT2A Layer 5 Pyramidal Neurons in the Prefrontal Cortex through a 5-HT2A Gq -mediated activation mechanismbioRxiv · 2022-11-15 Molecular insights into the regulation of constitutive activity by RNA editing of 5HT serotonin receptors.Cell reports · 2022-08-16 Molecular insights into psychedelic drug action.Journal of neurochemistry · 2022-07-01 The promises and perils of psychedelic pharmacology for psychiatry.Nature reviews. Drug discovery · 2022-06-01 The cranial windows of perception.Neuron · 2021-08-18 Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin.Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics · 2021-01-01 The emerging role of psilocybin and MDMA in the treatment of mental illness.Expert review of neurotherapeutics · 2020-12-01 Potential Therapeutic Effects of Psilocybin.Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics · 2017-07-01 Psilocybin for treating substance use disorders?Expert review of neurotherapeutics · 2017-02-01 Psilocybin for depression and anxiety associated with life-threatening illnesses.Journal of psychopharmacology (Oxford, England) · 2016-12-01 Effects of the hallucinogenic drugs mescaline, phencyclidine and psilocybin on zebrafish behavior and physiologyThe FASEB Journal · 2012-04-01 SAR of Psilocybin Analogues: Discovery of a Selective 5-HT2C Agonist.ChemInform · 2005-12-13 SAR of psilocybin analogs: discovery of a selective 5-HT2C agonist.Bioorganic & medicinal chemistry letters · 2005-10-15 Determination of psilocin and psilocybin using flow injection analysis with acidic potassium permanganate and tris(2,2′-bipyridyl)ruthenium(II) chemiluminescence detection respectivelyTalanta · 2005-08-15

Author directory